Tuesday, 17 November 2026

Nafthiromycin

 Nafithromycin is India's indigenously developed novel lactone-ketolide antibiotic, designed to treat community-acquired bacterial pneumonia, including infections caused by certain drug-resistant respiratory pathogens.



Theory To Practice 



Current Events

World Antimicrobial Resistance Awareness Week



Snapshot





































No comments:

Post a Comment